助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[108]条 当前为第1条到20条[由于搜索限制,当前仅支持显示前5页数据]
 

相关语句
renal-cell
Expression and significance of coxsackie and adenovirus receptor in renal-cell carcinoma
      
Allogeneic stem-cell transplantation in renal-cell carcinoma
      
Metastatic renal-cell carcinoma (RCC) remains resistant to nearly all standard cytotoxic therapies, but immune-based cytokine therapies benefit a small minority of patients with advanced RCC.
      
A phase I-II study of 9-cis retinoic acid and interferon-α2b in patients with advanced renal-cell carcinoma: An NCIC Clinical Tr
      
Although advanced renal-cell carcinoma (RCC) responds poorly to standardtherapies, phase I-II trials have shown activity for combinations ofinterferon-α2b (IFN) with a retinoid.
      
Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: Case report and review of the literature
      
The sarcomatoid variant of renal-cell carcinoma (SRCC), a clinicallyaggressive subtype of renal parenchymal tumors, is typically resistant tosystemic treatments and carries a poor prognosis.
      
Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: Clinical and laboratory effe
      
Background:Metastatic renal-cell carcinoma is a neoplasm that is minimally responsive to cytotoxic chemotherapy.
      
Isolated pancreatic metastases from renal-cell carcinomas (RCC) are extremely rare.
      
Only 96 cases of clinically diagnosed renal-cell carcinoma metastatic to the pancreas have been reported in the world literature, and 70 of the patients (including ours) underwent a definitive surgical resection.
      
The presence of TNF in human kidney tumors implies that renal-cell carcinoma cells in situ are resistant to the direct cytotoxic effect of TNF.
      
This resistance should be taken into account when TNF is considered for use as a possible immunotherapeutic agent in renal-cell carcinoma.
      
Between September 1990 and July 1991, we treated 17 patients with renal-cell carcinoma by radical nephrectomy and two patients with urothelial carcinoma of the kidney pelvis by ureteronephrectomy.
      
Phase I/II study of recombinant interferon α and γ in advanced progressive renal-cell carcinoma
      
A total of 32 patients with proven progressive renal-cell carcinoma were included.
      
Decrease in lymphokine-activated killer sensitivity of a human renal-cell carcinoma cell line after cytokine treatment
      
In this study, we analyzed the decrease in LAK sensitivity of a human renal-cell carcinoma cell line (SMKT-R-3).
      
However, the cytokine treatment increased the expression of intercellular adhesion molecule-1 (ICAM-1) on the renal-cell carcinoma cell surface.
      
The conjugate-formation assay also confirmed a slight increase in the binding rate of LAK cells to the renal-cell carcinoma cells.
      
 

首页上一页12345下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社